Medicinal Mushrooms
Show
- Stroke
- How Algernon Pharmaceuticals is aiming to use psychedelics to aid stroke recover
- Should Algernon’s trials succeed and it’s able to break barriers for therapeutic uses of psychedelics such as DMT, the potential number of patients is massive.
- 1939 0
- Medicinal Mushrooms
- Magic Mushrooms: Possible Cure for Depression and Anxiety?
- The past few years have seen vigorous campaigns by medical researchers to popularize alternative anxiolytic herbs
- 7407 0
- Inflammation
- Psychedelics Reported To Relieve Asthma With No Mental Effects
- “LSD, which is a super-potent psychedelic that produces behavioral effects at very low doses, is a relatively weak anti-inflammatory.
- 9067 0
- Medicinal Mushrooms
- Taking Magic Mushrooms Towards Phase 3 Trials
- London based biotech Compass Pathways has raised $80 million to bring its psilocybin therapy towards phase 3 development and prepare for trials
- 7209 0
-
- Stroke
- How Algernon Pharmaceuticals is aiming to use psychedelics to aid stroke recover
- Should Algernon’s trials succeed and it’s able to break barriers for therapeutic uses of psychedelics such as DMT, the potential number of patients is massive.
- 1939 0
-
- Medicinal Mushrooms
- Magic Mushrooms: Possible Cure for Depression and Anxiety?
- The past few years have seen vigorous campaigns by medical researchers to popularize alternative anxiolytic herbs
- 7407 0
-
- Inflammation
- Psychedelics Reported To Relieve Asthma With No Mental Effects
- “LSD, which is a super-potent psychedelic that produces behavioral effects at very low doses, is a relatively weak anti-inflammatory.
- 9067 0
-
- Medicinal Mushrooms
- Taking Magic Mushrooms Towards Phase 3 Trials
- London based biotech Compass Pathways has raised $80 million to bring its psilocybin therapy towards phase 3 development and prepare for trials
- 7209 0
Load More
